Merz Pharmaceuticals Introduces New Mederma® Advanced Scar Gel
/PRNewswire/ -- Mederma, the #1 doctor(1)-and pharmacist(2)-recommended brand for scars for over a decade, announced today the introduction of Mederma®...
www.prnewswire.comHere are the latest publicly available updates on Mederma and its brand status.
-
Ownership and brand structure
- In 2019, HRA Pharma announced it would acquire the Mederma brand from Merz, bringing Mederma into HRA Pharma’s consumer healthcare portfolio in the US and globally. This acquisition aimed to expand HRA Pharma’s presence in the scar care and related categories, subject to closing conditions and regulatory approvals.[1]
- Merz’s press materials at the time described Mederma and related products as part of Merz Aesthetics, with the sale marking a strategic shift for Merz away from non-aesthetic consumer skin-care lines.[1]
-
Product lineage and notable launches
- Mederma has historically introduced new scar management products, including Mederma Advanced Scar Gel, which emphasized one-daily application and included Cepalin (the onion-derived extract) as a core ingredient in its line.[2]
- Over the years, Mederma has promoted its breadth with products for adults and kids and marketing claims around improving texture, color, softness, and overall scar appearance.[2]
-
Industry recognition
- Mederma has repeatedly been cited as a leading brand in pharmacist- and physician-recommended scar-care products, with media outlets noting its long-standing recognition in scar and stretch-mark treatments.[3]
-
Current brand presence
- The Mederma brand continues to operate as part of the Merz/Merz Aesthetics lineage in many markets, and consumer-facing information (FAQs, product pages) remains available under the Mederma umbrella, including ongoing product lines and guidance on usage.[4][7]
-
Context on related coverage
- Media coverage historically highlighted Mederma’s status as a longstanding leader in scar care and stretch marks, including awards and pharmacist recommendations spanning multiple years.[3]
If you’d like, I can:
- Pull the most recent press releases or investor updates for 2024–2026 to confirm current ownership and product availability in your region (Los Angeles/California).
- Compile a quick chart of Mederma product launches and key claims over time.
- Provide direct links to current product pages and FAQs for up-to-date usage instructions.
Would you like me to fetch the latest press releases and product pages now?